Medicare Enrolled

Dr. Susan Watson, M.D.

Ophthalmology · Raleigh, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
11081 FOREST PINES DR, Raleigh, NC 27614
2522310424
In practice since 2006 (20 years)
NPI: 1184685646 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Watson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Watson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Watson

Dr. Susan Watson is an ophthalmology specialist in Raleigh, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Watson performed 352 Medicare services across 171 unique beneficiaries.

Between the years covered by Open Payments, Dr. Watson received a total of $6,183 from 26 pharmaceutical and/or device companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Watson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 352 Medicare services $6,183 industry payments

Medicare Practice Summary

Medicare Utilization ↗
352
Medicare services
Bottom 11% in NC for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
171
Unique beneficiaries
$205
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 130 $87 $190
Eye photography
Photographic imaging of the interior structures of the eye.
 97 $15 $90
Amniotic membrane placement on eye surface
This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing.
 56 $948 $1,691
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
 29 $130 $580
Eyelash removal with forceps
This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area.
 20 $19 $198
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
 20 $105 $210
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,183
Total received (2018-2024)
Avg $883/year across 7 years
Top 14% in NC for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
141
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,783 (61.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,400 (38.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,385
2023
$1,469
2022
$458
2021
$147
2020
$63
2019
$399
2018
$262

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Tarsus Pharmaceuticals, Inc.
$2,400
Bausch & Lomb Americas Inc.
$263
Harrow Eye, LLC
$210
Oyster Point Pharma, Inc.
$173
Mallinckrodt Hospital Products Inc.
$154
BIOTISSUE HOLDINGS INC.
$149
Alcon Vision LLC
$19
Johnson & Johnson Surgical Vision, Inc.
$17
Top 3 companies account for 84.9% of 2024 payments
All-time payments by company (2018-2024) ›
Tarsus Pharmaceuticals, Inc.
$2,400
BIOTISSUE HOLDINGS, INC.
$971
Oyster Point Pharma, Inc.
$614
Bausch & Lomb Americas Inc.
$439
Allergan Inc.
$235
Harrow Eye, LLC
$210
Johnson & Johnson Surgical Vision, Inc.
$160
Mallinckrodt Hospital Products Inc.
$154
BIOTISSUE HOLDINGS INC.
$149
RxSight Inc
$147
Sun Pharmaceutical Industries Inc.
$125
Dompe US, Inc.
$116
TissueTech, Inc.
$93
Alcon Vision LLC
$57
Carl Zeiss Meditec, Inc.
$56
Eyevance Pharmaceuticals LLC
$42
TISSUETECH, INC.
$41
Mallinckrodt Enterprises LLC
$32
Mallinckrodt LLC
$25
Thea Pharma Inc.
$23
Quidel Corporation
$20
BioTissue Holdings, Inc.
$19
Bausch & Lomb, a division of Bausch Health US, LLC
$18
Allergan, Inc.
$16
EYEVANCE PHARMACEUTICALS LLC
$14
NovaBay Pharmaceuticals, Inc.
$9
Top 3 companies account for 64.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Avenova · BROMSITE · CEQUA · CLARUS 500 Fundus Camera · EYSUVIS · Eye Health · Flarex · ILEVRO · IOLMaster 500 · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE) · LOTEMAX · MIEBO · OXERVATE · PROKERA · Prokera · RESTASIS · RESTASIS MULTIDOSE · Rocklatan · TYRVAYA · Tecnis IOL · VEVYE · VYZULTA · XDEMVY · XIIDRA · ZERVIATE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Raleigh?
Compare ophthalmologists in the Raleigh area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
144
Per 100K population
12.5
County median income
$101,763
Nearest hospital
TRIANGLE SPRINGS
8.9 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Watson is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of NC peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Watson experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Watson performed 130 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Watson receive payments from pharmaceutical companies?
Yes. Dr. Watson received a total of $6,183 from 26 companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Watson's costs compare to other ophthalmologists in Raleigh?
Dr. Watson's average Medicare payment per service is $205. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Watson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Ophthalmologists in Raleigh
Browse ophthalmologists in Raleigh ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in NC
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in NC
Which NC ophthalmologists receive the most from drug and device companies.
By company
Tarsus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Tarsus Pharmaceuticals, Inc.
By company
BIOTISSUE HOLDINGS, INC. Payments to Doctors
See all physicians who received payments from BIOTISSUE HOLDINGS, INC.
By company
Oyster Point Pharma, Inc. Payments to Doctors
See all physicians who received payments from Oyster Point Pharma, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →